What does CUSIP 19716T101 represent in this 13F holders report?

CUSIP 19716T101 is the security identifier for CLCD - COLUCID PHARMACEUTICALS INC - COM used to aggregate holder disclosures.

How many institutions held CLCD - COLUCID PHARMACEUTICALS INC - COM in Q4 2016?

75 institutional investors reported CLCD - COLUCID PHARMACEUTICALS INC - COM for Q4 2016. Use the holders table for investor-level position and value details.

COLUCID PHARMACEUTICALS INC - COM (CLCD)

CUSIP: 19716T101

Q4 2016 13F Holders as of 31 Dec 2016

Type / Class: Equity / COM
Total 13F shares: 13,802,147
Share change: +1,443,386
Total reported value: $502,413,000
Price per share: $36.40
Number of holders: 75
Value change: +$51,684,724
Number of buys: 45
Number of sells: 28

Quarterly Holders Quick Answers

What is CUSIP 19716T101?
CUSIP 19716T101 identifies CLCD - COLUCID PHARMACEUTICALS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q1 2017
Previous quarter: Q3 2016

Recent filing periods for CUSIP 19716T101:

Q2 2017 Q1 2017 Q4 2016 Q3 2016 Q2 2016 Q1 2016 Q4 2015 Q3 2015

Institutional Holders of COLUCID PHARMACEUTICALS INC - COM (CLCD) as of Q4 2016

As of 31 Dec 2016, COLUCID PHARMACEUTICALS INC - COM (CLCD) was held by 75 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 13,802,147 shares. The largest 10 holders included Novo A/S, PRICE T ROWE ASSOCIATES INC /MD/, FMR LLC, CITADEL ADVISORS LLC, PERCEPTIVE ADVISORS LLC, MARSHALL WACE, LLP, BVF INC/IL, GREAT POINT PARTNERS LLC, VANGUARD GROUP INC, and SPHERA FUNDS MANAGEMENT LTD.. This page lists 75 institutional shareholders reporting positions in this security for the Q4 2016 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.